Can Buspirone Make You Hungry or Affect Your Appetite?

Buspirone is widely regarded as one of the more “weight-neutral” psychiatric medications, but that reputation glosses over a more complicated reality. Animal research consistently shows buspirone can stimulate food intake through serotonin pathways, and a handful of human observations hint that appetite changes do occur in some people. The picture gets even more interesting when you consider buspirone’s separate effects on the stomach itself, which can push appetite in the opposite direction depending on the dose and the situation.

How Buspirone Interacts With Hunger Signaling

Buspirone’s primary job is to reduce anxiety by acting on serotonin 5-HT1A receptors in the brain. But those same receptors play a role in appetite regulation. When buspirone activates certain serotonin autoreceptors, it temporarily dials down overall serotonin activity in parts of the brain that help regulate eating behavior. Since serotonin is one of the key signals your brain uses to say “you’re full, stop eating,” lowering that signal can tip the balance toward hunger.

Lab studies in rats have demonstrated this clearly. Buspirone, along with related compounds gepirone and ipsapirone, produced dose-dependent increases in food intake when given to freely feeding rats.¹ The researchers concluded that all three drugs were acting as serotonin autoreceptor agonists in the feeding model, essentially mimicking a signal that reduces serotonin’s appetite-suppressing effect.² Buspirone wasn’t even the strongest appetite stimulant in the group. It worked over a narrower dose range than the other two compounds, and its peak effect on eating was smaller.

There’s also a dopamine component. When researchers pre-treated rats with a dopamine-blocking drug before giving buspirone, the appetite-stimulating effect was significantly weakened.¹ So the hunger boost isn’t purely a serotonin story. Buspirone’s weak dopamine receptor activity appears to contribute, which matters because dopamine is deeply involved in the reward and motivation aspects of eating.

Dose Matters More Than You’d Think

One of the most consistent findings in animal research is that buspirone’s appetite effects are sharply dose-dependent, and not in a simple “more drug equals more hunger” way. In one study, food intake increased at a low dose of buspirone but higher doses had no effect at all.³ This held true for both single doses and repeated administration. The appetite stimulation appeared only at the bottom end of the dosing range.

This inverted pattern is unusual compared to most drugs, where higher doses tend to produce stronger effects. For buspirone, it likely reflects the fact that low doses preferentially hit the autoreceptors that suppress serotonin release, while higher doses start activating postsynaptic serotonin receptors too, which can have the opposite effect on appetite. In practical terms, if you’re taking a low starting dose and notice increased hunger, it doesn’t necessarily mean that ramping up to your full therapeutic dose will make the hunger worse. It might actually go away.

Buspirone and the Stomach

Separate from anything happening in the brain, buspirone has a direct physical effect on the stomach that can change how hunger and fullness feel. The drug relaxes the upper part of the stomach, known as the fundus, allowing it to expand more easily after a meal. In a clinical trial of patients with functional dyspepsia, buspirone significantly increased gastric accommodation compared to placebo and improved symptoms of postprandial fullness, upper abdominal bloating, and early satiation.⁴

This is worth pausing on because the appetite implications cut in two directions. On one hand, if your stomach can accommodate more food comfortably, you might eat larger portions before feeling uncomfortable. On the other hand, buspirone also slowed gastric emptying of liquids in the same trial, meaning food stays in the stomach longer. Slower emptying generally makes you feel full for a longer stretch after eating. Case reports have echoed these findings, with doses above roughly 20 mg per day appearing to slow the rate of gastric emptying and doses above 30 mg promoting greater stomach relaxation.⁵

For people who already have digestive issues like functional dyspepsia, this stomach-relaxing effect is a feature, not a bug. But for someone without those problems, the same mechanism might subtly alter how hungry or full they feel at different points during and after meals. You could end up eating more comfortably at each sitting while also feeling satisfied for longer afterward, which is a wash for many people in terms of total intake.

The Stress-Eating Connection

One of buspirone’s more interesting appetite effects has to do with stress. Severe stress often kills appetite entirely, a phenomenon well-documented in both animals and humans. Buspirone appears to counteract that suppression. In rats subjected to restraint stress (a standard lab stressor), buspirone reversed the stress-induced loss of appetite and body weight. The researchers attributed this to a “hyperphagic action” on 5-HT1A receptors, essentially an appetite-boosting effect that kicked in specifically when stress had shut eating down.⁶

This finding maps onto something many people taking buspirone for anxiety experience. If your anxiety has been suppressing your appetite, you may notice that as the drug starts working and your anxiety eases, food becomes more appealing again. This isn’t a direct pharmacological increase in hunger so much as a removal of the thing that was blocking it. The distinction matters because it means the “increased appetite” is really your appetite returning to something closer to baseline. People in this situation often gain a few pounds initially, attribute it to the medication, and worry about long-term weight gain that may never materialize once their eating patterns stabilize.

What Real-World Human Data Shows

The animal evidence for buspirone stimulating appetite is fairly robust. The human evidence is thinner and more mixed. Buspirone has been prescribed for decades, and the clinical trials that led to its approval did not flag appetite increase or weight gain as common side effects. The standard prescribing information lists nausea and occasional digestive complaints, not hunger.

However, a large pharmacovigilance study that analyzed real-world adverse event reports submitted to the FDA’s FAERS database did detect a signal for abnormal body weight, including obesity, associated with buspirone use. The numbers were small, with only 19 reports of obesity flagged, but the statistical signal was strong enough that the researchers called it noteworthy and deserving of further attention.⁷ Pharmacovigilance databases capture voluntary reports from clinicians and patients, so they don’t tell you how common an effect is in the broader population. What they do well is surface rare signals that controlled trials, with their limited sample sizes and durations, might miss.

Nineteen reports out of a database covering millions of prescriptions is genuinely rare. But the fact that the signal emerged at all in a drug traditionally considered weight-neutral suggests that for a small subset of people, clinically meaningful weight gain does happen. Whether that’s driven by increased hunger, metabolic changes, or the indirect effects of reduced anxiety on eating behavior isn’t clear from the adverse-event data alone.

The Other Direction: Can Buspirone Cause Weight Loss?

In a twist that makes the appetite picture even harder to pin down, some animal research suggests buspirone can actually cause weight loss under certain conditions. In spontaneously hypertensive rats, treatment with buspirone led to decreased body weight and abdominal fat compared to untreated controls. The researchers found that buspirone activated a cellular pathway involved in energy production and fat metabolism.⁸

This is a specific animal model with metabolic abnormalities that don’t directly translate to healthy humans. But it reinforces a theme that keeps recurring with buspirone: its effects on appetite and body weight are context-dependent. In stressed animals, it increases eating. In metabolically abnormal animals, it may reduce weight. In normal freely feeding animals, it boosts intake at low doses and does nothing at higher ones. The drug doesn’t simply flip a switch in one direction.

Menstrual Cycle and Hormonal Timing

One small but intriguing human study explored whether buspirone’s appetite effects vary with the menstrual cycle. Nine healthy women who were not taking hormonal contraception received single doses of buspirone at different points in their cycle. Food intake after a 20 mg dose was significantly higher during the luteal phase, the roughly two-week window between ovulation and the start of a period, compared to other phases.⁹ The researchers suggested this could reflect pre-menstrually enhanced sensitivity of serotonin receptors.

This is only one study with a tiny sample, so the specific numbers shouldn’t be taken as definitive. But the broader point resonates with what many women already know from experience: hunger fluctuates across the cycle, and medications that touch serotonin pathways can interact with those fluctuations. If you notice that buspirone seems to affect your appetite more at certain times of the month, it’s not in your head, and there’s at least a plausible biological explanation for why.

Blood Sugar Effects

There’s a separate metabolic angle that could indirectly influence hunger. Research on goldfish (an established model for certain hormonal and metabolic studies, though obviously far from human) found that buspirone decreased blood glucose levels, possibly by increasing insulin secretion through serotonergic receptor stimulation.¹⁰ Lower blood sugar is one of the classical triggers for hunger, so if buspirone does affect glucose metabolism in humans, it could create a physiological push toward eating even in the absence of a direct brain-driven appetite signal.

No well-controlled human studies have confirmed this glucose-lowering effect in people taking buspirone at therapeutic doses for anxiety. It remains a mechanistic possibility rather than a proven clinical phenomenon. Still, if you’re someone who experiences episodes of feeling shaky, irritable, or suddenly ravenous on buspirone, disrupted glucose handling is one hypothesis worth mentioning to your prescriber, especially if you have pre-existing blood sugar concerns.

How Buspirone Compares to Other Psychiatric Medications

Part of why buspirone has its weight-neutral reputation is context. The medications it’s often compared to, particularly SSRIs, SNRIs, benzodiazepines, and certain antipsychotics, have much more dramatic and well-documented effects on weight. Some antidepressants like mirtazapine and paroxetine are strongly associated with weight gain. Several antipsychotics can cause rapid and substantial increases in body weight. Against that backdrop, buspirone’s mild and inconsistent appetite effects barely register.

For people switching from an SSRI to buspirone, or adding buspirone to an existing antidepressant regimen, weight considerations often favor the switch. Buspirone doesn’t carry the metabolic baggage that many other psychiatric drugs do. But “much better than mirtazapine on weight” isn’t the same as “no effect on appetite,” and patients sometimes feel dismissed when they report hunger or weight changes that their prescriber attributes to something else because buspirone “doesn’t do that.”

When Anxiety Itself Was Suppressing Appetite

One scenario worth separating from direct pharmacological effects is the person whose anxiety was dramatically suppressing their eating. Chronic anxiety often manifests as nausea, stomach upset, or simply no interest in food. When buspirone successfully treats that anxiety, the gastrointestinal symptoms ease and appetite returns. A case report of a four-year-old boy with severe anxiety, feeding difficulties, and poor weight gain illustrated this clearly: treatment with buspirone was associated with decreased anxiety, improved self-feeding skills, and weight gain.¹¹ The weight gain in that case wasn’t a side effect. It was a therapeutic success, reflecting the removal of anxiety-driven eating avoidance.

This pattern appears in adults too, though it’s harder to tease apart from medication effects. If you lost weight during a period of severe anxiety and then gained it back after starting buspirone, the question of whether buspirone “caused” the weight gain becomes almost philosophical. The drug treated the condition that was suppressing your appetite. Your appetite recovered. Whether you call that a side effect or a recovery depends on your starting point.

Nausea as the Overlooked Appetite Suppressor

Nausea is one of buspirone’s more commonly reported side effects, especially in the first week or two of treatment. For some people, this overshadows any appetite-stimulating properties entirely. You might have a pharmacological nudge toward eating more, but if the drug also makes you feel queasy, the net result is eating less, at least initially. As nausea fades with continued use (which it usually does), any underlying appetite stimulation may become more noticeable. This timing can confuse people: they feel fine on buspirone for a few weeks, then suddenly notice they’re hungrier, and wonder whether something changed. What often changed is just that the nausea left.

Digestive side effects also interact with the gastric accommodation effects described earlier. Buspirone relaxes the upper stomach and slows emptying, which in some people reduces bloating and discomfort, and in others initially adds to it. Individual anatomy and baseline digestive function play a bigger role than most people expect in determining whether buspirone makes eating feel easier or harder.

Practical Takeaways for People Starting Buspirone

If you’re about to start buspirone or recently began taking it, a few things are worth keeping in mind. First, large-scale appetite increases and rapid weight gain are not a typical response. If you gain more than a few pounds in the first month, it’s worth talking to your prescriber rather than assuming it’s inevitable. Second, mild increases in appetite, especially at lower doses and during the first several weeks, are consistent with what the pharmacology would predict. Eating slightly more isn’t a reason to stop a medication that’s helping your anxiety, but tracking it helps you distinguish a real trend from a passing fluctuation. Third, if your anxiety previously killed your appetite, expect it to come back as the drug works, and plan for that by having reasonable meals available rather than relying on whatever’s at hand when hunger suddenly returns after weeks of not eating enough.

The evidence, taken together, paints buspirone as a drug that genuinely can affect appetite through multiple pathways: serotonin-mediated hunger signaling, dopamine-driven food motivation, physical changes in stomach accommodation, stress-appetite interactions, and possibly glucose regulation. But these effects are modest, dose-dependent, context-sensitive, and in some cases push in opposite directions. For most people, buspirone remains one of the gentler psychiatric medications on body weight. For a small minority, the appetite effects are real enough to notice and worth managing proactively.